- Home
- LXEH vs GNTA Comparison
LXEH vs GNTA Comparison
Compare LXEH & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$0.29
HOLD
Current Price
$1.61
Company Overview
Basic Information| Metric | LXEH | GNTA |
|---|---|---|
| Founded | 2001 | 2014 |
| Country | China | Italy |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1M | 41.7M |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | LXEH | GNTA |
|---|---|---|
| Price | $0.29 | $1.61 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 201.2K | 106.2K |
| Earning Date | 12-30-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $4,585,942.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.27 | $1.35 |
| 52 Week High | $50.08 | $10.00 |
Technical Indicators
Market Signals| Indicator | LXEH | GNTA |
|---|---|---|
| Relative Strength Index (RSI) | 28.31 | 30.36 |
| Support Level | $0.27 | $1.80 |
| Resistance Level | $0.30 | $2.07 |
| Average True Range (ATR) | 0.02 | 0.18 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 14.05 | 0.00 |
Price Performance
Historical Comparison LXEH
GNTA
About LXEH Lixiang Education Holding Co. Ltd.
Lixiang Education Holding Co Ltd is a private primary and secondary education service provider in Lishui City, Zhejiang Province. Its private education services primarily include primary and middle school education from grade 1 to grade 9. The company also offers high school education services at its High School Divisions.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.